Neogenomics Laboratories Inc

Neogenomics Laboratories Inc ( NEOGENOMICS LABORATORIES INC ) is (1) Clinical Medical Laboratory Provider in Fort Myers, FL. The NPI Number for Neogenomics Laboratories Inc is 1073549663.

The current location address for Neogenomics Laboratories Inc is 12701 COMMONWEALTH DR SUITE 9 Fort Myers, FL 33913 and the contact number is 2397680600 and fax number is 2396904236. The mailing address for Neogenomics Laboratories Inc is PO BOX 864110 Orlando, FL 32886- 2397680600 (mailing address contact number - 2397680600).

(1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.

What is the NPI Number for Neogenomics Laboratories Inc ?

Answer: The NPI Number for Neogenomics Laboratories Inc is 1073549663

Where is Neogenomics Laboratories Inc located?

Answer: Neogenomics Laboratories Inc is located at 12701 COMMONWEALTH DR SUITE 9 Fort Myers, FL 33913.

What is the specialty for Neogenomics Laboratories Inc ?

Answer: The Specialty of Neogenomics Laboratories Inc is (1) Clinical Medical Laboratory Provider.

Are there any online reviews for Neogenomics Laboratories Inc ?

Answer: Not yet!

Are there any other health care providers in Fort Myers, FL?

Answer: Yes, there are given below...

Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Neogenomics Laboratories Inc

Number of HCPCS	84
Number of Medicare Beneficiaries	22749
Number of Services	129816
Total Submitted Charge Amount	27892255.7
Total Medicare Allowed Amount	14920515.49
Total Medicare Payment Amount	12456087.57
Total Medicare Standardized Payment Amount	12199607.39
Drug Suppress Indicator
Number of HCPCS Associated With Drug Services	0
Number of Medicare Beneficiaries With Drug Services	0
Number of Drug Services	0
Total Drug Submitted Charge Amount	0
Total Drug Medicare Allowed Amount	0
Total Drug Medicare Payment Amount	0
Total Drug Medicare Standardized Payment Amount	0
Medical Suppress Indicator
Number of HCPCS Associated With Medical Services	84
Number of Medicare Beneficiaries With Medical	22749
Number of Medical Services	129816
Total Medical Submitted Charge Amount	27892255.7
Total Medical Medicare Allowed Amount	14920515.49
Total Medical Medicare Payment Amount	12456087.57
Total Medical Medicare Standardized Payment Amount	12199607.39
Average Age of Beneficiaries	75
Number of Beneficiaries Age Less 65	1452
Number of Beneficiaries Age 65 to 74	9393
Number of Beneficiaries Age 75 to 84	8899
Number of Beneficiaries Age Greater 84	3005
Number of Female Beneficiaries	11447
Number of Male Beneficiaries	11302
Number of Non-Hispanic White Beneficiaries	18681
Number of Black or African American Beneficiaries	1858
Number of Asian Pacific Islander Beneficiaries	469
Number of Hispanic Beneficiaries	1103
Number of American Indian/Alaska Native Beneficiaries	45
Number of Beneficiaries With Race Not Elsewhere Classified	593
Number of Beneficiaries With Medicare & Medicaid Entitlement	2799
Number of Beneficiaries With Medicare Only Entitlement	19950
Percent (%) of Beneficiaries Identified With Atrial Fibrillation	0.16
Percent (%) of Beneficiaries Identified With Alzheimer's Disease or Dementia	0.12
Percent (%) of Beneficiaries Identified With Asthma	0.08
Percent (%) of Beneficiaries Identified With Cancer	0.27
Percent (%) of Beneficiaries Identified With Heart Failure	0.26
Percent (%) of Beneficiaries Identified With Chronic Kidney Disease	0.47
Percent (%) of Beneficiaries Identified With Chronic Obstructive Pulmonary Disease	0.18
Percent (%) of Beneficiaries Identified With Depression	0.24
Percent (%) of Beneficiaries Identified With Diabetes	0.35
Percent (%) of Beneficiaries Identified With Hyperlipidemia	0.68
Percent (%) of Beneficiaries Identified With Hypertension	0.75
Percent (%) of Beneficiaries Identified With Ischemic Heart Disease	0.44
Percent (%) of Beneficiaries Identified With Osteoporosis	0.11
Percent (%) of Beneficiaries Identified With Rheumatoid Arthritis / Osteoarthritis	0.47
Percent (%) of Beneficiaries Identified With Schizophrenia / Other Psychotic Disorders	0.01
Percent (%) of Beneficiaries Identified With Stroke	0.06
Average HCC Risk Score of Beneficiaries	1.7333